ERIN ROWAN: Open Payments
NPI 1396118972 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 74 payments from 17 companies in 2025. Trend: 2023 $1,803 · 2024 $2,007 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $287 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $229 |
| ABBVIE INC. | 9 | $148 |
| Axsome Therapeutics, Inc. | 6 | $138 |
| Lilly USA, LLC | 6 | $116 |
| Abbott Laboratories | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| PFIZER INC. | 3 | $62 |
| Novo Nordisk Inc | 3 | $57 |
Products named: Kerendia, FARXIGA, Auvelity, JARDIANCE, FREESTYLE LIBRE 3, UBRELVY, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
